From 1936 to the present day, FDC has come a long way.
Presenting the various turning points along the FDC journey:
| 1936 |
Mr. Anand Chandavarkar set up FairDeal Corporation (FDC) to import drugs, infant foods and surgical appliances for distribution in India |
| 1949 |
Formulation plant established in Jogeshwari, Mumbai |
| 1963 |
FairDeal introduced Vanmycetin Eye Drops – starting point for its ophthalmic and ENT range |
| 1972 |
Electral introduced by FairDeal – a result of pioneering work in rehydration therapy |
| 1974 |
FairDeal's R&D facilities obtain recognition from the Govt. of India |
| 1977 |
Active Pharmaceutical Ingredient (API) plant commissioned at Roha, Maharashtra |
| 1984 |
Foods division set up for manufacture of specialized infant foods at Roha |
| 1985 |
First US FDA approval of API plant at Roha |
| 1986 |
FairDeal Corporation (Pvt.) Ltd. was renamed FDC Pvt. Ltd. and thereafter FDC Limited |
| 1987 |
Commissioned a formulation Plant at Waluj, Aurangabad (Maharashtra) |
| 1989 |
Began commercial production of Flurbiprofen |
| 1991 |
Biotechnology research center set up at Waluj. Started production of Timolol Maleate (API). |
| 1992 |
National Award from the Council of Scientific Research and Industry for Indigenous R&D of Flurbiprofen and Timolol |
| 1994 |
FDC became the first company in India to introduce ophthalmics in blow-fill-seal packs, which optimize sterility and are highly user friendly |
| 1996 |
FDC established a specialized & dedicated field force to promote its ophthalmic specialties |
| 1996 |
FDC awarded ‘Export House' status |
| 1996 |
Public issue of 26, 28, 200 equity shares of Rs. 10 each at a premium of Rs. 90 each |
| 1998 |
UK-MHRA approval for ophthalmic facility at Waluj |
| 1999 |
Formed a JV in UK |
| 2002 |
First UK-MHRA approval for oral solids facility at Goa |
| 2003 |
Re-organized Indian marketing operations into 3 divisions – Spectra, Select and Proxima |
| 2004 |
Established JV in South Africa |
| 2004 |
JV in the UK converted to a Wholly Owned Subsidiary |
| 2005 |
Filed 2 ANDAs for ophthalmic dosage forms in the U.S. |
| 2005 |
First US-FDA approval for ophthalmic facility at Waluj |
| 2005 |
Ranked 22nd in India (IMS) |
